Practical aspects of extended half-life products for the treatment of haemophilia

Haemophilia A and haemophilia B are congenital X-linked bleeding disorders caused by deficiency of coagulation factor VIII (FVIII) and IX (FIX), respectively. The preferred treatment option for patients with haemophilia is replacement therapy. For patients with severe disease, prophylactic replaceme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Hematol
Autors principals: Lambert, Thierry, Benson, Gary, Dolan, Gerry, Hermans, Cedric, Jiménez-Yuste, Victor, Ljung, Rolf, Morfini, Massimo, Zupančić-Šalek, Silva, Santagostino, Elena
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6130100/
https://ncbi.nlm.nih.gov/pubmed/30210757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718796429
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars